Allena Pharmaceuticals
Latest round
- Series C
Last raised
- Dec 2015
Total raised
- $93M
Investors
- 8
About Allena Pharmaceuticals
Founded in 2011 and headquartered in Newton, US, Allena Pharmaceuticals specializes in oral enzyme therapies for metabolic conditions.67 mn.87 mn.Allena Pharmaceuticals specializes in the development of novel oral enzyme therapies aimed at addressing difficult-to-treat metabolic diseases, particularly enteric hyperoxaluria, hyperuricemia, and gout. The company's core offering includes a first-in-class oral biologic platform designed to reduce oxalate levels in patients suffering from enteric hyperoxaluria. Additionally, Allena is developing a non-absorbed urate-degrading enzyme aimed at breaking down urate in the gastrointestinal tract, providing a potential solution for hyperuricemia and gout patients, particularly those with reduced kidney function.Allena Pharmaceuticals operates a business model centered around partnerships and collaborations with healthcare providers and organizations focusing on metabolic diseases. The revenue structure is primarily driven by the commercialization of its enzyme therapies, including direct sales to healthcare facilities and prescriptions through pharmacies. The company also aims to explore additional indications for ALLN-177, such as oxalate nephropathy and primary hyperoxaluria, while developing new product candidates leveraging its non-systemic oral protein therapeutic platform. Allena is focused on expanding its market reach in North America and Europe to enhance accessibility to its innovative therapies.
Who invested in Allena Pharmaceuticals
8 investors across 3 rounds
See all investors in Allena Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Allena Pharmaceuticals
Who invested in Allena Pharmaceuticals?
Allena Pharmaceuticals has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allena Pharmaceuticals raised?
Allena Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Allena Pharmaceuticals last raise money?
Allena Pharmaceuticals's most recent round on record is a Series C, in Dec 2015.
What does Allena Pharmaceuticals do?
Founded in 2011 and headquartered in Newton, US, Allena Pharmaceuticals specializes in oral enzyme therapies for metabolic conditions.
Where is Allena Pharmaceuticals headquartered?
Allena Pharmaceuticals is headquartered in Newton, US.
Which VCs invest in companies like Allena Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allena Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Allena Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.